Navigation Links
DNA size a crucial factor in genetic mutations, study finds

Researchers at Stanford University have created a larger-than-normal DNA molecule that is copied almost as efficiently as natural DNA. The findings, reported in the Oct. 25 online edition of the Proceedings of the National Academy of Sciences (PNAS), may reveal new insights into how genetic mutations-tiny mistakes that occur during DNA replication-arise. The discovery was made in the laboratory of Eric Kool, a professor of chemistry at Stanford and co-author of the PNAS study.

DNA, the genetic encoder of life, comes in two parallel strands that form a double helix. It's like a long, twisted ladder where each rung consists of two molecules that form a base pair. DNA has four bases: adenosine (A), thymine (T), guanine (G) and cytosine (C). A always pairs with T, and G with C. To copy itself, the DNA molecule unwinds and splits. Either strand is now a template to build a new DNA molecule. An enzyme-a protein that speeds the reaction, in this case the bacteria E. coli's DNA polymerase I-moves along the template and selects the corresponding base to create a new base pair.

DNA bases fit into a specialized site on the enzyme before they are bonded to the template. Kool wanted to see how the enzyme reacts if the bases are not the usual size. ''The idea was to see how DNA replication depends on size,'' Kool says.

The researchers investigated it by offering bases of different sizes to the DNA polymerase I enzyme and measuring how accurately the enzyme made new DNA copies. About once every 10,000 to 100,000 times the enzyme will put in the wrong base, choosing for instance a G instead of a T to pair with an A. The rate that the enzyme accurately copies DNA is known as its efficiency.

These rare and random mistakes can cause genetic mutations. While we tend to heap negative connotations onto the term, some mutations create new traits that actually benefit the organism or yield no effect. These small-scale changes, collectively called genetic drif t, play an important role in evolution, as does natural selection.

To make their DNA bases, Kool started with a molecule similar to thymine-called an analog-and made five different sizes by adding increasingly larger atoms. The first analog was smaller than natural thymine, the second about the same size and the last three were increasingly larger. The difference between the smallest and largest analogs was only one angstrom, or a tenth of a nanometer.

Bigger is better

When the researchers offered the analog bases to DNA polymerase I, the enzyme not only recognized the synthetic molecules as it would natural DNA but also copied one of the slightly larger analogs at a rate 22 times more efficiently than the natural-sized analog. In fact, DNA polymerase I incorporated the slightly larger analog almost as efficiently as it did natural thymine, both in the test tube and in live E. coli bacteria. In contrast to this, the smallest and largest analogs in the set were rejected by the enzyme and the bacteria.

According to Kool, these results indicate that size is a strong factor determining enzyme efficiency-and a mechanism for allowing mutations into the DNA molecule.

''It's a way the organism can evolve,'' Kool says. ''If the protein that copies DNA prefers a molecule that's slightly bigger than natural DNA, then it can accept mistakes more readily.'' For example, although T is supposed to match up with A, it might be inclined to pair with G, which has a slightly larger configuration.

The sheer fact that a living system readily used a base-or nucleotide-that was artificially created is itself groundbreaking. ''Here we have, I think, the first example of an efficient, human-designed nucleotide working in a live cell,'' he says.

Kool and the gang are now exploring ''the funny finding that the bugs prefer DNA that's larger than natural DNA'' by making larger nucleotides. ''Size and shape are related issues, so we 're interested now in keeping the size constant and changing the shape,'' Kool adds.


Source:Stanford University

Related biology news :

1. Epstein-Barr virus protein crucial to its role in blood cancers
2. Researchers identify protein crucial for survival of Lyme-disease bacterium
3. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
4. Scientists discover the bodys marijuana-like compounds are crucial for stress-induced pain relief
5. Einstein scientists discover how protein crucial for motion is synthesised at the right place in the cell
6. Source of crucial immune cell in the skin discovered
7. Researchers add crucial information on how the bodys T cells react to parasitic diseases
8. Heart has enough oxygen to survive hypothermia, CPR crucial
9. Scientists identify protein with a crucial role in cell death
10. Neural stem cell gene plays crucial role in eye development
11. Brown team finds crucial protein role in deadly prion spread
Post Your Comments:

(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: